Search Results - "Smugar, S.S"

Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis by Bingham, C.O., M.D, Bird, S.R., M.S, Smugar, S.S., M.D, Xu, X., Ph.D, Tershakovec, A.M., M.D., M.P.H

“…Summary Objectives To determine the proportion of responders in two identical osteoarthritis (OA) trials using Outcome Measures in Arthritis Clinical…”
Get full text

Protection against Exercise-Induced Bronchoconstriction Two Hours after a Single Dose of Montelukast in Children by Wasfi, Y, Kemp, J.P, Villarán, C, Massaad, R, Xin, W, Smugar, S.S, Knorr, B.A, Philip, G

“…Eligible patients were to receive single-dose montelukast (4 or 5 mg) or placebo before performing standardized exercise challenges at 2 and 24 hours postdose…”
Get full text

A walking model to assess the onset of analgesia in osteoarthritis knee pain by Peeva, E, Beals, C.R, Bolognese, J.A, Kivitz, A.J, Taber, L, Harman, A, Smugar, S.S, Moskowitz, R.W

“…Summary Objective To assess a walking model utilizing a set of standardized treadmill walks to measure acute analgesic response in osteoarthritis (OA) of the…”
Get full text

A Responder Analysis Of Montelukast Compared With Placebo For Protection Against Exercise-Induced Bronchoconstriction - Pooled Results From 3 Studies by Philip, G, Pearlman, D.S, Loeys, T, Legrand, C, Smugar, S.S, Reiss, T.F

“…Conclusions Montelukast, compared with placebo, was associated with low proportions of Nonresponders and high proportions of Responders at all timepoints…”
Get full text

LDL-C REDUCTION AND GOAL ACHIEVEMENT IN PATIENTS WITH DIABETES, METABOLIC SYNDROME, OR NEITHER DISEASE, STRATIFIED BY NCEP CHD RISK CATEGORY by Catapano, A.L., Polis, A., Abate, N., Ballantyne, C.M., Davidson, M.H., Smugar, S.S., Tershakovec, A.M.

Get full text